Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3.

Platz EA, Pollak MN, Willett WC, Giovannucci E.

J Am Acad Dermatol. 2000 Jun;42(6):1003-7.

PMID:
10827403
2.

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

Stattin P, Bylund A, Rinaldi S, Biessy C, Déchaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R.

J Natl Cancer Inst. 2000 Dec 6;92(23):1910-7.

3.
5.

Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.

Ma J, Giovannucci E, Pollak M, Chan JM, Gaziano JM, Willett W, Stampfer MJ.

J Natl Cancer Inst. 2001 Sep 5;93(17):1330-6.

6.

Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men.

Platz EA, Pollak MN, Rimm EB, Majeed N, Tao Y, Willett WC, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1107-10.

7.

Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women.

Probst-Hensch NM, Wang H, Goh VH, Seow A, Lee HP, Yu MC.

Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):739-46.

8.
10.
11.

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E.

J Natl Cancer Inst. 2002 Jul 17;94(14):1099-106.

12.

Hormones and hair patterning in men: a role for insulin-like growth factor 1?

Signorello LB, Wuu J, Hsieh Cc, Tzonou A, Trichopoulos D, Mantzoros CS.

J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):200-3.

PMID:
10025745
13.

Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.

Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.

Breast Cancer Res Treat. 2004 Nov;88(1):63-73.

PMID:
15538047
14.

Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.

Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, van Gils CH, Peeters PH.

Cancer Causes Control. 2004 Oct;15(8):787-96.

PMID:
15456992
15.

Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.

Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.

Endocr Relat Cancer. 2006 Jun;13(2):583-92.

16.

Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer.

Tricoli JV, Winter DL, Hanlon AL, Raysor SL, Watkins-Bruner D, Pinover WH, Hanks GE.

Urology. 1999 Jul;54(1):178-82.

PMID:
10414748
17.

Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer.

Winter DL, Hanlon AL, Raysor SL, Watkins-Bruner D, Pinover WH, Hanks GE, Tricoli JV.

Urology. 2001 Oct;58(4):614-8.

PMID:
11597555
18.

Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.

Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB.

Growth Horm IGF Res. 2008 Dec;18(6):506-16. doi: 10.1016/j.ghir.2008.04.005. Epub 2008 Jun 11.

PMID:
18550406
19.

Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study.

Szulc P, Joly-Pharaboz MO, Marchand F, Delmas PD.

Calcif Tissue Int. 2004 Apr;74(4):322-9.

PMID:
15255068
20.
Items per page

Supplemental Content

Write to the Help Desk